Prolacta secures funding for second processing facility and larger sales force:
Prolacta Bioscience(R) Secures Series D Funding from Health Evolution Partners - MarketWatch: Prolacta Bioscience(R) Secures Series D Funding from Health Evolution Partners
-- New Members Added to Prolacta Board of Directors --
MONROVIA, Calif., Nov 03, 2011 (BUSINESS WIRE) -- Prolacta Bioscience, the first and only company to offer human milk fortifier (HMF) made from 100% human breast milk for critically ill, premature infants, has announced that they have secured Series D funding from Health Evolution Partners (HEP). HEP invests in rapidly growing companies that are commercial leaders in the healthcare industry. The funding will be used primarily to fund a second facility and to support growth of Prolacta's sales organization....